ONWARD Medical Enrolls First Participant in Global Study for Blood Pressure Stability

ONWARD Medical has initiated Empower BP, a pivotal study focusing on the ARC-IM® System, an implantable technology designed to stabilize blood pressure in individuals with spinal cord injuries (SCI). This landmark investigation marks the first global evaluation of ONWARD's implantable spinal cord stimulation device.

The study, involving approximately 20 centers worldwide, aims to address the unmet need for managing blood pressure instability post-SCI. The first participant has been enrolled at Craig Hospital in Denver, indicating the trial's commencement.

The ARC-IM System targets symptoms like orthostatic hypotension and autonomic dysreflexia, significantly affecting quality of life and cardiovascular health. Previous studies have noted improvements in hemodynamic stability, leading to enhanced everyday functioning and reduced reliance on traditional treatments.